Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Split

65 clinical trials in Split, Croatia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Split at a glance
65
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

65 trials in Split

Open in trial search

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:ADX-324
  • Sponsor:Adarx Pharmaceuticals Inc.

Asthma

Recruiting

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:ADX-324
  • Sponsor:Adarx Pharmaceuticals Inc.

Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Mediar Therapeutics Inc.

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Split

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on autoimmune disorders including trials for new treatments of Sjögren's Syndrome, Systemic Lupus Erythematosus, and Psoriatic Arthritis. Studies are evaluating novel therapeutic approaches to manage symptoms and improve patient outcomes.

  • Systemic Sclerosis Treatment
  • Lupus Nephritis Management
  • Immunological Response Studies
02 Inflammatory Diseases

Comprehensive research into inflammatory conditions, with trials examining treatments for Crohn's Disease and Ulcerative Colitis. Studies are investigating combination therapies and long-term maintenance treatments to improve disease management.

  • Gastrointestinal Disorders
  • Dermatological Conditions
  • Novel Treatment Approaches
03 Neurological Disorders

Advanced clinical trials exploring treatments for Multiple Sclerosis, with studies comparing the efficacy of new medications against established therapies. Research includes both adult and pediatric populations with relapsing-remitting forms of the disease.

  • MS Treatment Innovations
  • Pediatric MS Studies
  • Disease Modification Research
04 Oncology Research

Cutting-edge studies in cancer treatment, including trials for breast cancer and multiple myeloma. Research focuses on targeted therapies and novel treatment combinations to improve patient outcomes.

  • Hematological Malignancies
  • Breast Cancer Therapies
  • Targeted Treatment Approaches
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.